Reach More Sanofi Patients Where They Watch

Your patients are watching TV. Are you reaching them?

The Challenge

Linear TV campaign in June

Ad Spend

$7,653,800.00

Missed Opportunity

61%

of target patients NOT reached

Only 38.7% reach rate = 7.1M at $1078.00 per 1,000

Sanofi missed 61% of its target audience in June 2025.

Only 7.1 million of 80.9 million reachable patients saw the campaign, leaving more than 49 million unseen. These are patients who fit your ideal profile but never encountered your message. Every unserved viewer represents a missed opportunity to educate, influence, and build trust.

We know your patients are watching TV.

However, they are not being reached.

With TV+, Sanofi could expand reach by 24% - without increasing spend.

By unifying connected and linear TV, TV+ eliminates duplication and uncovers previously undervalued audiences. The result: greater efficiency, stronger awareness, and more patients reached where they actually watch.

Your Competition Isn't Reaching Patients Either

Rinvoq also struggles with patient reach

Rinvoq Campaign

69% unreached = Missed patient opportunities

Your competition isn’t reaching patients either

Even AbbVie’s Rinvoq campaign faced the same challenge - only 31% reach, leaving 69% of potential patients unserved. When every brand shares the same blind spots, the one that moves first beyond those boundaries wins.

Maximize Your Patient Reach with TV+

TV+ dramatically expands your reach beyond current campaigns

TV+ Optimization Solution

Current reach: 38.7% (7.1M at $1078.00/1K)

Maximize your patient reach with TV+

With TV+, Sanofi could increase reach by 14% using the same budget. Imagine turning 38.7% reach into more than 50% - delivering incremental scale without incremental spend.

Limited Time Offer